The parallel rise of ICAM-1, observed in the present study, goes along with previous findings obtained in the SHRSP, where a decrease of this inflammatory and endothelial integrity marker represented a substantial achievement of strategies aimed to combat stroke [21–23]. The gene discussed is ICAM1; the disease is Stroke.